If you’re interested in cannabis stocks but don’t know where to start, here are a few reasons why you should pay attention to what’s happening in this space, and why you need to keep a close eye on what American Premium Water Corporation (OTC:HIPH) is doing.
With the success of the 2018 Farm Bill in the rearview, publicily traded companies are already setting their sights on the next hot trend: CBD-infused beverages.
CBD-infused beverages are expected to rapidly grow in popularity in the coming years. This growth is fueled by an increasing demand for functional beverages made with healthy, natural ingredients and increasing public awareness of the health and wellness benefits of CBD.
According to one estimate, the CBD drinks market in the U.S. will be worth $260 million by the year 2022, while another estimate says the combined value of CBD and THC-infused beverages will reach $1.4 billion by 2024. But these numbers are just the beginning, as the legal cannabis industry is expected to grow to tens of billions further down the line.
By 2029, the global cannabis market could be as big as $130 billion, with CBD beverages contributing a significant portion.
2019 is set to be the breakout year for this industry, as dozens of companies are beginning to launch their CBD water, tea, and other hemp-infused drinks.
International demand for CBD infused products has increased exponentially over the past year.
The CBD beverage industry is poised to see a massive growth and American Premium Water Corporation (OTC: HIPH) has done a fantastic job of taking a lead in this fast-growing industry.
American Premium Water Corporation (OTC: HIPH) continue to expand more rapidly, not just in North America and Europe, but also throughout Asia, Latin America and Australia.
According to a recent press release, the company announced that it is engaged in discussions with distributors in Australia, Mexico, and Colombia to sell the Company’s products. Both CBD and non-CBD products will be sold to these distributors. Exploratory discussions are also underway with distributors in the Pacific Rim region. The Company expects sales to begin in these regions in the 3rd and 4th quarter of 2019.
After announcing the independent verification of the efficacy of its proprietary Hydro Nano technology, the Company has expanded its operations to the UK, where it has setup a sales team to cover the country and continental Europe. Since February, the team has been responsible for generating a two-container order with a local distributor.
The company have also setup a relationship with Hanlons Brewery to manufacture CBD infused beer. In addition the team established a partnership with Lynne Franks to produce CBD infused women’s wellness products. This led the Company to provide revenue guidance of $1million for the 2019 fiscal year.
We believe the market is undervaluing HIPH’s strong long-term top-line growth potential.
The Company was recently given a short-term price target of $0.05-$0.06 by Ludlow Research. To read the full report, click here